BX Swiss TOP 30 CHF
1.282,58
PKT
+6,31
PKT
+0,49
%
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
Datum | Rating | Analyst | |
---|---|---|---|
21.10.21 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
21.10.21 | UBS Buy | UBS AG | |
21.10.21 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
21.10.21 | Roche Neutral | UBS AG | |
21.10.21 | ABB (Asea Brown Boveri) Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
21.10.21 | Nestlé Buy | Goldman Sachs Group Inc. | |
21.10.21 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
21.10.21 | Roche Neutral | JP Morgan Chase & Co. | |
21.10.21 | Nestlé Overweight | JP Morgan Chase & Co. | |
21.10.21 | Nestlé Buy | UBS AG | |
21.10.21 | Roche Neutral | Credit Suisse Group | |
20.10.21 | Nestlé Add | Baader Bank | |
20.10.21 | Nestlé Sector Perform | RBC Capital Markets | |
20.10.21 | Roche Outperform | Bernstein Research | |
20.10.21 | UBS Overweight | Barclays Capital | |
20.10.21 | Nestlé Buy | Goldman Sachs Group Inc. | |
20.10.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
20.10.21 | Roche Overweight | Barclays Capital | |
20.10.21 | Nestlé Buy | UBS AG | |
20.10.21 | Nestlé Buy | Kepler Cheuvreux | |
20.10.21 | Roche Hold | Kepler Cheuvreux | |
20.10.21 | Roche Neutral | UBS AG | |
20.10.21 | ABB (Asea Brown Boveri) Buy | Kepler Cheuvreux | |
20.10.21 | Nestlé Overweight | JP Morgan Chase & Co. | |
20.10.21 | Roche Buy | Jefferies & Company Inc. | |
20.10.21 | Nestlé Sector Perform | RBC Capital Markets | |
20.10.21 | Roche Neutral | JP Morgan Chase & Co. | |
19.10.21 | UBS Buy | Kepler Cheuvreux | |
19.10.21 | Givaudan Underweight | Barclays Capital | |
18.10.21 | UBS Outperform | Credit Suisse Group | |
18.10.21 | Nestlé Buy | UBS AG | |
15.10.21 | ABB (Asea Brown Boveri) Equal Weight | Barclays Capital | |
15.10.21 | Holcim Neutral | JP Morgan Chase & Co. | |
14.10.21 | ABB (Asea Brown Boveri) Buy | UBS AG | |
14.10.21 | Swiss Re Sell | UBS AG | |
14.10.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
14.10.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
14.10.21 | Roche Outperform | Bernstein Research | |
14.10.21 | Givaudan Underperform | Jefferies & Company Inc. | |
13.10.21 | Roche Neutral | JP Morgan Chase & Co. |